Express Scripts seeks clout from WellPoint deal-WEB ONLY
Express Scripts Inc. stands to gain considerable negotiating clout from its $4.68 billion deal to buy the pharmacy benefits management businesses of health insurer WellPoint Inc., and experts say that could mean savings for customers buying prescription drugs. St. Louis-based Express Scripts said yesterday it planned to buy Indianapolis-based WellPoint’s NextRx subsidiaries in a cash-and-stock […]